Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis

Published:2010-10 Issue:10 Volume:105 Page:2186-2194
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Kumagi Teru,Guindi Maha,Fischer Sandra E,Arenovich Tamara,Abdalian Rupert,Coltescu Catalina,Heathcote Jenny E,Hirschfield Gideon M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2010216.pdf

Reference26 articles.

1. Primary biliary cirrhosis.;Kaplan;N Engl J Med,2005

2. Time course of histological progression in primary biliary cirrhosis.;Locke;Hepatology,1996

3. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis.;Lindor;Gastroenterology,1996

4. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.;Poupon;N Engl J Med,1991

5. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.;Lindor;Gastroenterology,1994

Cited by 305 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired ductopenia: an insight into imaging findings;Abdominal Radiology;2024-07-02

2. Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis;JHEP Reports;2024-07

3. Long-term outcomes in patients with primary biliary cholangitis complicated with CREST syndrome;Scientific Reports;2024-06-19

4. PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old;Clinics and Research in Hepatology and Gastroenterology;2024-06

5. Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid;European Journal of Internal Medicine;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3